CPT Code Change Will Expand Heart Failure Treatment Adoption

Published
29 Mar 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$10.83
35.1% undervalued intrinsic discount
15 Aug
US$7.03
Loading
1Y
-12.9%
7D
-2.9%

Author's Valuation

US$10.8

35.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 7.96%

Shared on24 Apr 25
Fair value Decreased 30%

AnalystConsensusTarget has increased shares outstanding growth rate from 0.1% to 0.2%.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 53%

AnalystConsensusTarget has decreased future PE multiple from 57.8x to 50.3x.

Shared on02 Apr 25